Xiuning Le, Mike Hernandez, Simon Heeke, Andreas Saltos, John V. Heymach. "Reply to: Osimertinib Plus Antiangiogenic Agents: A Promising New Paradigm With Uncertain Results." Journal of Clinical Oncology, 2025. doi:10.1200/jco-25-00032